2011年1月
Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach
BREAST CANCER
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- 巻
- 18
- 号
- 1
- 開始ページ
- 64
- 終了ページ
- 67
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.1007/s12282-010-0198-5
- 出版者・発行元
- SPRINGER JAPAN KK
A suggestive case of metastatic disease from breast cancer is reported. The HER-2-positive tumor was refractory to several agents, including anti-HER-2 therapy, trastuzumab, and lapatinib. After re-induction of trastuzumab in combination with activated natural killer (NK) cell injection therapy, tumor markers decreased, and finally a synergistic effect of taxane and capecitabine led to treatment response. This case suggests that multidisciplinary therapy including an immunological approach might be a breakthrough in the treatment of refractory disease.
- リンク情報
-
- DOI
- https://doi.org/10.1007/s12282-010-0198-5
- J-GLOBAL
- https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201102276358806436
- CiNii Articles
- http://ci.nii.ac.jp/naid/10027894715
- PubMed
- https://www.ncbi.nlm.nih.gov/pubmed/20354831
- Web of Science
- https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000289303500011&DestApp=WOS_CPL
- ID情報
-
- DOI : 10.1007/s12282-010-0198-5
- ISSN : 1340-6868
- eISSN : 1880-4233
- J-Global ID : 201102276358806436
- CiNii Articles ID : 10027894715
- PubMed ID : 20354831
- Web of Science ID : WOS:000289303500011